"our work on in vitro targeting NOTCH in #lymphoma with ⁦@CellestiaBio⁩ CB-103 is out. ⁦@IOR_Bellinzona⁩ ⁦@USI_en⁩ ⁦@EnteOspedaliero⁩ ⁦@AnastasiosStat2⁩ ⁦@CascioneLuciano⁩ https://t.co/IwqYQSVKVQ"

CB-103 - Cellestia Biotech

Dec 17, 2022